MIRA INFORM REPORT

 

 

Report No. :

336166

Report Date :

13.08.2015

 

IDENTIFICATION DETAILS

 

Name :

BALKANFARMA DUPNITSA AD

 

 

Registered Office :

Ul. Samokovsko Shose No. 3 2600 Dupnitsa

 

 

Country :

Bulgaria

 

 

Financials (as on) :

31.12.2014

 

 

Year of Establishment :

1989

 

 

Legal Form :

Joint Stock Company (AD)

 

 

Line of Business :

  • Manufacture of pharmaceutical preparations
  • Production of generic medicines in pills and capsules.

 

 

No. of Employees :

1262

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Bulgaria

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

BULGARIA - ECONOMIC OVERVIEW

 

Bulgaria, a former Communist country that entered the EU on 1 January 2007, averaged more than 6% annual growth from 2004 to 2008, driven by significant amounts of bank lending, consumption, and foreign direct investment. Successive governments have demonstrated a commitment to economic reforms and responsible fiscal planning, but the global downturn sharply reduced domestic demand, exports, capital inflows, and industrial production. GDP contracted by 5.5% in 2009, and has been slow to recover in the years since. Despite having a favorable investment regime, including low, flat corporate income taxes, significant challenges remain. Corruption in public administration, a weak judiciary, and the presence of organized crime continue to hamper the country's investment climate and economic prospects.

 

Source : CIA

COMPANY DETAILS

 

Local name: BALKANFARMA DUPNITSA AD

International name: BALKANPHARMA - DUPNITSA JSC

 

Registered address:

ul. Samokovsko shose No. 3

2600 Dupnitsa

Bulgaria
Telephone: +359-701-58477, +359-701-56333, +359-701-58186

Fax:            +359-701-58555

E-Mail:       dupoperations@actavis.bg

Internet:      http://www.actavis.bg

 

ESTABLISHMENT & REGISTRATION:

Established: 1989

Registered at Kyustendil district court

Court number I-2280/1991

Bulstat/VAT number: 819364374

 

Status of the company:

Active

 

HISTORY:

The company was established before 1989 as a state factory FARMACIA DUPNITZA.
In 1999 the agency of privatization sold company (together with two other pharmaceutical companies) to BALKANPHARMA HOLDING AD (owned 99.8% by PHARMACO, Iceland) and the company was renamed to BALKANPHARMA DUPNITZA.

In 2004 BALKANPHARMA HOLDING AD was renamed to AKTAVIS AD.

 

LEGAL FORM:

Joint Stock Company (AD)

 

REGISTERED CAPITAL:

BGN 3 317 655.00

 

BANKERS:

BNP Paribas (Bulgaria) AD

 

 

SHAREHOLDERS/MANAGEMENT

 

SHAREHOLDERS:

AKTAVIS OPERATIONS EOOD

98.05%

ID 131485378

Others

1.95%

 

 

MANAGEMENT:

Petar Mitev Petrov

(Personal ID 6202242969 )

- Representative, Member of the board

Ivan Ganev Urumov

(Personal ID 6706037560 )

- Representative, Member of the board

Milen Rusev Shopov

(Personal ID 7511262446)

- Member of the board

Antoaneta Atanasova Grancharska

(Personal ID 6409022897)

- Member of the board

Nikola Todorov Samardjiev

(Personal ID 7509117283 )

- Member of the board

 

 

RELATED COMPANIES:

 

Company ID

Company Name

826043874

BULMASO

130028818

BALKANFARMA SEKYURITI

820174176

BALKANFARMA - TROYAN AD

 

 

BUSINESS ACTIVITY

 

BUSINESS OPERATION:

NACE 1.1: 24.42 Manufacture of pharmaceutical preparations

 

Activity:

Production of generic medicines in pills and capsules.

 

 

NUMBER OF EMPLOYEES:

 

As at date

Value

31.12.2006

1167

31.12.2007

1156

31.12.2008

1007

31.12.2009

746

31.12.2010

676

31.08.2011

1167

05.10.2012

967

06.06.2013

1028

31.12.2013

1094

22.09.2014

1153

31.12.2014

1173

Latest stand

1262


http://www.imoe.de/creditreport/temp/employ.jpg

 

EXPORT:

Albania, Armenia, Macedonia, USA, EU

 

IMPORT:

Brazil, India, Indonesia, Israel, Malaysia, Macedonia, Thailand, USA, EU

 

REAL ESTATE:

Own production plant.

 

 

FINANCIAL DATA

 

TURNOVER:

 

Year

Currency

Value

1998

BGN

76 726 166.00

1999

BGN

41 235 000.00

2000

BGN

92 850 000.00

2001

BGN

109 494 000.00

2002

BGN

98 388 000.00

2003

BGN

106 723 000.00

2004

BGN

99 362 000.00

2005

BGN

102 796 000.00

2006

BGN

115 657 000.00

2007

BGN

89 493 000.00

2008

BGN

79 663 000.00

2009

BGN

74 187 000.00

2010

BGN

89 243 000.00

2011

BGN

165 592 000.00

2012

BGN

209 769 000.00

2013

BGN

236 824 000.00

2014

BGN

251 414 000.00

 


turnover

 

MODES OF PAYMENT:

Payments are within contracted terms.

 

DEBT COLLECTION:

No debt collection cases are registered against the company.

 

BANK DISTRAINTS:

No shares of the company are under bank distraint.

 

UNPAID TAXES/ CONTRIBUTIONS TO GOVERNMENT:

There is no publication about overdue unpaid taxes.

 

INVOLVEMENT IN LEGAL DISPUTES:

There is no publication about legal claims or disputes against the company.

 

OTHER PAYMENT INFORMATION:

No adverse payment information is available.

 

BRANCH INDICATOR:

The company's payment behaviour is average for the branch.

 

GENERAL PAYMENT ASSESSMENT:

 

FINANCIAL OPINION:

A+ 

 

 

Exchange rate since 1998 is 1 BGN (denominated lev) = 0.51 EUR

 

Ratio

2011

2012

2013

2014

Accounting period: 

1.1.2011 -
31.12.2011

1.1.2012 -
31.12.2012

1.1.2013 -
31.12.2013

1.1.2014 -
31.12.2014

Debt ratio

0.05

0.09

0.08

0.12

Quick ratio

10.66

5.50

5.32

3.41

Current ratio

12.99

6.97

7.06

5.17

Days purchase in payables

32.70

59.31

51.34

76.66

Operating margin in %

14.13

14.27

11.70

11.12

Cash ratio (acid ratio)

0.01

0.02

0.01

0.00

Return on sales ROS in %

12.83

12.73

10.53

9.99

Return on assets ROA in %

6.64

6.84

6.27

5.53

Return on equity ROE in %

7.00

7.57

6.93

6.36

Days supply in inventory

75.45

86.91

89.51

134.95

Days sales in receivables

348.16

325.08

272.51

261.10

 

 

BALANCE SHEET in BGN'000

2011

2012

2013

2014

Accounting period: 

1.1.2011 -
31.12.2011

1.1.2012 -
31.12.2012

1.1.2013 -
31.12.2013

1.1.2014 -
31.12.2014

A.UNPAID CAPITAL

 

 

 

 

B. FIXED ASSETS

 

 

 

 

I Fixed Intangible Assets:

 

 

 

 

R&D Products

 

288

185

82

Concessions, patents, trade-marks

 

1389

1204

727

Goodwill

 

 

 

 

Intangible fixed assets under construction

 

225

 

160

thereof advances

 

 

 

 

Total I:

1489

1902

1389

969

II Fixed Tangible Assets

 

 

 

 

Land and Buildings

 

39014

37948

37082

thereof Land

 

1311

1311

1311

thereof Buildings

 

37703

36637

35771

Machines, Vehicles

 

81101

94347

100537

Equipment

 

7882

7615

7510

Tangible fixed assets under construction

 

8422

13829

21562

thereof advances

 

 

 

 

Total II

123199

136419

153739

166691

III. Fixed Financial Assets

 

 

 

 

Shares in group companies

 

 

 

 

Loans granted to group companies

 

 

 

 

Shares in joint ventures

 

 

 

 

Long term investments

 

1

1

1

Other loans

 

 

 

 

Bought back own shares

 

 

 

 

Total III

1

1

1

1

IV. Deferred Taxes

0

476

730

641

B. FIXED ASSETS TOTAL

124689

138798

155859

168302

C. CURRENT ASSETS

 

 

 

 

I. Inventories

 

 

 

 

Raw Materials

 

19248

29300

54855

Work in progress

 

18239

17173

24534

thereof young animals

 

 

 

 

Trading goods

 

9624

11191

10476

thereof production

 

9624

11191

10476

thereof goods for sale

 

 

 

 

Advances

 

 

 

 

Total I

34705

47111

57664

89865

II. Receivables

 

 

 

 

Receivables from customers

 

2035

1063

1181

thereof more than 1 year

 

 

 

 

Receivables from group companies

 

168662

171362

170264

thereof more than 1 year

 

 

 

 

Receivables from joint ventures

 

 

 

 

thereof more than 1 year

 

 

 

 

Other receivables

 

5510

3131

2422

thereof more than 1 year

 

1533

 

 

Total II

160146

176207

175556

173867

III. Current Financial Assets

 

 

 

 

Current investments in related companies

 

 

 

 

Bought back own shares

 

 

 

 

Other current financial assets

 

 

 

 

Total III

0

 

 

 

IV. Cash equivalents

 

 

 

 

Cash and accounts in the country

 

728

353

200

thereof cash

 

4

1

3

Thereof cash in foreign currency (equivalent)

 

1

2

2

thereof current accounts

 

723

350

195

thereof blocked accounts

 

 

 

 

thereof cash equivalents

 

 

 

 

Cash and accounts abroad

 

 

 

 

thereof cash

 

 

 

 

Thereof cash in foreign currency (equivalent)

 

 

 

 

thereof current accounts

 

 

 

 

thereof blocked accounts

 

 

 

 

Total IV

126

728

353

200

C. CURRENT ASSETS TOTAL

195376

224046

233573

263932

D. Deferred expenses

399

310

282

442

TOTAL ASSETS

320065

363154

389714

432676

A. OWNERS EQUITY

 

 

 

 

I. Share capital

3318

3318

3318

3318

II. Issue premium

 

 

 

 

III. Revaluation reserves

 

 

 

 

thereof revaluation reserves of financial instruments

 

 

 

 

IV. Reserves

 

 

 

 

legal reserves

 

332

332

332

reserve related to bought back own shares

 

 

 

 

reserve from company foundation

 

 

 

 

other reserves

 

9326

9469

9469

Total IV

9800

9658

9801

9801

V. Result from previous period

 

 

 

 

Undistributed profit

 

290136

314832

339259

Uncovered loss

 

 

 

 

Total V

290136

290136

314832

339259

VI. Current result profit (loss)

 

24839

24427

23939

A. OWNERS EQUITY TOTAL

303254

327951

352378

376317

B. PROVISIONS

 

 

 

 

Provisions for pensions

 

576

689

723

Provisions for taxes

 

2477

3572

4587

thereof deferred taxes

 

2477

3572

4587

Other provisions

 

 

 

 

B. PROVISIONS TOTAL

 

3053

4261

5310

C. LIABILITIES

 

 

 

 

Bond-backed loans

 

 

 

 

less than 1 year

 

 

 

 

more than 1 year

 

 

 

 

Bank loans

 

24

 

 

less than 1 year

 

24

 

 

more than 1 year

 

 

 

 

Advances received

 

 

 

 

less than 1 year

 

 

 

 

more than 1 year

 

 

 

 

Payables to suppliers

 

22012

13998

29319

less than 1 year

 

22012

13998

29319

more than 1 year

 

 

 

 

Liabilities on policies

 

 

 

 

less than 1 year

 

 

 

 

more than 1 year

 

 

 

 

Liabilities to group companies

 

5748

14598

16291

less than 1 year

 

5748

14598

16291

more than 1 year

 

 

 

 

Liabilities to joint-venture companies

 

 

 

 

less than 1 year

 

 

 

 

more than 1 year

 

 

 

 

Other liabilities

 

4366

4479

5439

less than 1 year

 

4366

4479

5439

more than 1 year

 

 

 

 

thereof to personnel

 

1290

1408

1611

less than 1 year

 

1290

1408

1611

more than 1 year

 

 

 

 

thereof to social insurance

 

672

852

991

less than 1 year

 

672

852

991

more than 1 year

 

 

 

 

thereof for taxes

 

30

136

175

less than 1 year

 

30

136

175

more than 1 year

 

 

 

 

C. LIABILITIES TOTAL

16811

32150

33075

51049

less than 1 year

15039

32150

33075

51049

more than 1 year

1772

 

 

 

D. FINANCING AND DEFERRED INCOME

 

 

 

 

thereof

 

 

 

 

Financing

 

 

 

 

Deferred income

 

 

 

 

TOTAL EQUITY AND LIABILITIES

320065

363154

389714

432676

 

 

P&L ACCOUNT in BGN'000

2011

2012

2013

2014

Accounting period: 

1.1.2011 -
31.12.2011

1.1.2012 -
31.12.2012

1.1.2013 -
31.12.2013

1.1.2014 -
31.12.2014

A. EXPENSES

 

 

 

 

I. OPERATION EXPENSES

 

 

 

 

Decrease of inventories

 

 

 

 

thereof for materials

 

133975

161660

166265

thereof for services

 

10152

10764

10408

Personnel expenses

 

16994

19991

22577

thereof wages

 

14571

17129

19251

thereof social insurance

 

2423

2862

3325

thereof pensions

 

 

 

 

Depreciation

 

12410

14413

16335

thereof Depreciation of fixed assets

 

12410

14413

16335

Other expenses

 

8937

7569

10142

thereof Book value of sold assets (without production)

 

4117

4173

4489

I. OPERATION EXPENSES TOTAL

142011

182468

214397

225727

II. Financial expenditures

 

 

 

 

Depreciation of financial assets

 

1508

1852

2821

thereof exchange rate losses

 

1508

1852

2821

Paid interest

 

29

43

33

thereof interest to group companies

 

 

15

 

Thereof expenditures for securities operations

 

 

 

 

II. Financial expenditures Total

1809

1537

1895

2854

B. Profit on ordinary activity

23398

27840

27142

26648

III. Extraordinary expenses

0

 

 

 

thereof expenses on disasters and emergency expenses

 

 

 

 

C. Total expenses (I+II+III)

143820

184005

216292

228581

D. Accounting profit

23398

27840

27142

26648

IV. Taxation on profit

2160

2375

1874

1605

V. Other taxes

 

626

841

1104

E. Net profit

21238

24839

24427

23939

Total expenses

167218

211845

243434

255229

A. REVENUES

 

 

 

 

I . OPERATING REVENUES

 

 

 

 

Net sales

165592

195135

231919

239727

Production

 

192434

229835

235067

Goods

 

 

 

 

Services

 

2701

2084

4660

Increase of production and work in progress

 

8062

501

6646

Expenses on acquisition of assets

 

 

 

 

Other revenues

 

6572

4404

5041

thereof financing

 

 

 

 

I. TOTAL OPERATING REVENUES

165592

209769

236824

251414

II FINANCIAL REVENUES

 

 

 

 

Income from shares

 

 

 

 

thereof income from shares in group companies

 

 

 

 

Income from investments and loans

 

 

 

 

thereof from investments in group companies

 

 

 

 

Income from interest

 

2076

6610

3815

thereof from interest from group companies

 

357

3804

2997

II FINANCIAL REVENUES TOTAL

1626

2076

6610

3815

TOTAL REVENUES FROM ORDINARY ACTIVITIES

167218

211845

243434

255229

LOSS

 

 

 

 

Extraordinary revenues

0

 

 

 

AFTER TAX LOSS

0

 

 

 

TOTAL REVENUES

167218

211845

243434

255229

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.64.83

UK Pound

1

Rs.101.00

Euro

1

Rs.71.82

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

TRU

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.